Full-Time

Research Associate I/II

CRISPR Delivery Engineering

Posted on 3/7/2024

Scribe Therapeutics

Scribe Therapeutics

51-200 employees

Develops CRISPR-based genetic medicine platforms

Biotechnology

Compensation Overview

$68,000 - $90,000Annually

+ Additional Incentives

Junior

Alameda, CA, USA

Requirements
  • A BS/BA in Bioengineering, Cell or Molecular Biology, Synthetic Biology, or related discipline
  • 2+ years wet lab research experience required
  • Experience with mammalian cell and bacterial culture, molecular cloning and common bioassays required
  • Expertise in use of mammalian cell reporter systems, screening in human cells, and readout by FACS and NGS analysis is a plus
  • Experience with CRISPR-Cas gene editing systems and AAV transductions desired
  • Ability to work collaboratively in a fast-paced, interdisciplinary research team
  • Demonstrated quantitative and scientific thinker as evidenced by a strong publication record
  • Excellent prioritization and organization skills
Responsibilities
  • Work closely with AAV engineering leads to creatively design, rapidly build, and efficiently screen AAV vectors for the controllable delivery of genome editing tools to target human cells and tissues
  • As part of the screening projects, they will be responsible for cloning and producing high quality plasmids for AAV production, and the in vitro testing of AAV vectors in a variety of target cell lines
  • Design and execute hypothesis-driven and properly controlled studies, analyze data with rigorous statistics, and write up publication quality reports
  • Effectively collaborate with members within a fully integrated team to facilitate execution on projects within established timelines
  • Effectively present updates, and communicate research plans and timelines to the senior leadership team
  • Foster a driven, fast-paced, dynamic, and fun environment in which to do rigorous science

Scribe Therapeutics is engaged in pioneering advancements in genetic medicine, utilizing CRISPR-based technologies aimed at precise genome editing and specific targeting. Their focus on innovative delivery technologies and commitment to achieving exceptional specificity within the genome positions them as a leader in the biotechnology field. This commitment to cutting-edge science and precise therapeutic impacts offers a stimulating environment for professionals passionate about genetic research and development.

Company Stage

Series B

Total Funding

$140.2M

Headquarters

Alameda, California

Founded

2017

Growth & Insights
Headcount

6 month growth

6%

1 year growth

22%

2 year growth

119%
INACTIVE